Top Companies
Form Screener
Cluster Buys
Sectors
FAQ
Feedback
Blog
Pricing
Login/Signup
ARS Pharmaceuticals, Inc. (SPRY)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Billed Annually
SAVE 20%/mo!
Billed Monthly
Director
$50/mo
* Billed monthly
All Insider Trades
Monthly Newsletter
Unlimited Company Graphs
Download Data
Sector Insights
Custom Watchlists
Notifications
Real Time Emails
Direct Access to Team
Feature Requests
C-Suite
$75/mo
* Billed monthly
All Insider Trades
Monthly Newsletter
Unlimited Company Graphs
Download Data
Sector Insights
Custom Watchlists
Notifications
Real Time Emails
Direct Access to Team
Feature Requests
Checkout
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Sep 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-32%
100,000
$7.71
$770,520.00
BUY
29 Aug 2023
Thompson Peter A.
Director
ARS Pharmaceuticals, Inc.
(SPRY)
8,019,187
+6%
500,000
$6.20
$3,100,000.00
BUY
29 Aug 2023
RA CAPITAL MANAGEMENT, L.P.
Director
ARS Pharmaceuticals, Inc.
(SPRY)
5,856,774
+177%
3,750,000
$6.20
$23,250,000.00
BUY
29 Aug 2023
ORBIMED ADVISORS LLC
Director
ARS Pharmaceuticals, Inc.
(SPRY)
8,019,187
+6%
500,000
$6.20
$3,100,000.00
SELL
3 Aug 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-17%
45,004
$7.03
$316,489.30
SELL
1 Aug 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-20%
54,996
$7.12
$391,840.75
SELL
7 Jul 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-4%
8,858
$6.36
$56,372.31
SELL
3 Jul 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-30%
91,142
$6.48
$590,453.30
SELL
1 Jun 2023
Shawver Laura
Director
ARS Pharmaceuticals, Inc.
(SPRY)
210,346
-32%
100,000
$6.84
$684,041.10
BUY
29 Nov 2022
Scott Kathleen D.
Chief Financial Officer, Officer
ARS Pharmaceuticals, Inc.
(SPRY)
8,250
+100%
8,250
$6.24
$51,506.40
BUY
3 Mar 2021
ROOT JONATHAN D
Director
Silverback Therapeutics, Inc.
(SBTX)
2,364
+100%
2,364
$15.25
$36,048.40
BUY
8 Dec 2020
ROOT JONATHAN D
Director
Silverback Therapeutics, Inc.
(SBTX)
95,238
+100%
95,238
$21.00
$1,999,998.00
BUY
8 Dec 2020
CAPPS VICKIE L
Director
Silverback Therapeutics, Inc.
(SBTX)
61,576
+18%
9,523
$21.00
$199,983.00
BUY
8 Dec 2020
Presidio Management Group XII, L.L.C.
10% Owner
Silverback Therapeutics, Inc.
(SBTX)
47,619
+100%
47,619
$21.00
$999,999.00
BUY
8 Dec 2020
Hawkinson Russ
Sr. Vice President of Finance, Officer
Silverback Therapeutics, Inc.
(SBTX)
238
+100%
238
$21.00
$4,998.00
BUY
8 Dec 2020
Schroeder Thilo
Director
Silverback Therapeutics, Inc.
(SBTX)
238,096
+100%
238,096
$21.00
$5,000,016.00
BUY
8 Dec 2020
Piazza Jonathan
Chief Financial Officer, Officer
Silverback Therapeutics, Inc.
(SBTX)
11,904
+100%
11,904
$21.00
$249,984.00
BUY
8 Dec 2020
Thompson Peter A.
Director, 10% Owner
Silverback Therapeutics, Inc.
(SBTX)
507,423
+174%
1,190,477
$21.00
$25,000,016.00
BUY
8 Dec 2020
ORBIMED ADVISORS LLC
Director, 10% Owner
Silverback Therapeutics, Inc.
(SBTX)
507,423
+174%
1,190,477
$21.00
$25,000,016.00
Home